Mutational signature-based classification of ampullary carcinoma
Dec 31, 2024, 09:36

Mutational signature-based classification of ampullary carcinoma

Erman Akkus, Medical oncology fellow at the Ankara University, shared a recent article by Ekaterina Zhuravleva on X: 

“Mutational signature-based classification of ampullary carcinoma in Gut Journal.

Cluster 1-2: want pathway.

Cluster 3: Immunogenic (better sırvival).

ICIs and want pathway-targeted therapies.”

Title: Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma

Authors: Ekaterina Zhuravleva, Monika Lewinska, Colm J O’Rourke, Antonio Pea, Asif Rashid, Ann W Hsing, Andrzej Taranta, David Chang, Yu-Tang Gao, Jill Koshiol, Rui Caetano Oliveira and Jesper B Andersen

ampullary carcinoma

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.

More posts featuring Erman Akkus.